Qiagen N.V. cash flow to debt ratio of 39.55% indicates that the company generates enough cash to cover its debts. This level indicates strong financial health.

Qiagen N.V.'s free cash flow has decreased 10.49% from $506.38M last year to $453.28M, signaling decreasing performance

Qiagen N.V.'s debt to equity ratio is 0.49, which means that the company's assets are healthy financed, signaling financial stability.

Qiagen N.V.'s debt has increased relative to shareholder equity from 0.45 last year to 0.49 today, signaling weakened financials

Qiagen N.V. has a net debt to EBITDA ratio of 0.77x, which is below the 3.00x threshold, indicating healthy leverage and financial stability

Qiagen N.V. earns at least as much interest as it pays. Interest obligations are fully covered.

Qiagen N.V.'s profit margin has increased (361.19%) in the last year from 4.23% to 19.49%, signaling increasing performance

Qiagen N.V.'s short-term assets of $2.00B exceed its short-term liabilities of $512.14M

Qiagen N.V.'s return on assets of 6.95% is higher than the 5.00% threshold, indicating efficient asset utilization

Qiagen N.V.'s return on equity of 11.60%, is lower than 15.00%, indicating bad performance

Qiagen N.V.'s operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation

Qiagen N.V. had positive net income in 5 out of 5 years, indicating stable and consistent earnings

Qiagen N.V. has positive free cash flow, indicating the company generates cash after capital expenditures

Qiagen N.V. has a free cash flow yield of 5.01%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

Qiagen N.V.'s yearly earnings has increased 408.28% since last year from $83.59M to $424.88M, signaling increasing performance

Qiagen N.V.'s yearly revenue has increased 5.65% since last year from $1.98B to $2.09B, signaling increasing performance

ROIC 9.00% (Source: FMP key-metrics). In the 5–10% partial-credit band. Score: 1 of 2. This band sits within the typical US weighted-average cost of capital range. Methodology choice can change the conclusion: under FMP's invested-capital definition the company is at or near its cost of capital; under narrower operating-capital definitions the same company may score higher. Invested capital here includes equity, non-current liabilities, and short-term debt. Cash is not subtracted. See methodology.

Qiagen N.V.'s 3-year revenue CAGR of -0.81% is negative, indicating declining revenue over the past 3 years

Qiagen N.V. had revenue growth in 3 out of 5 years, indicating consistent revenue performance

Qiagen N.V. had positive ROE in 5 out of 5 years, indicating consistent and reliable returns on equity

Qiagen N.V. is overvalued relative to its fair value price of 35.09 based on Discounted Cash Flow model

Qiagen N.V. has an earnings yield of 4.52%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings

Qiagen N.V. is overvalued relative to its fair value price of 20.41 based on EBITDA multiple model

Qiagen N.V. has an EV/EBITDA ratio of 13.38x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings

Qiagen N.V. is overvalued relative to its fair value price of 26.58 based on Earnings Fair Value model

Qiagen N.V. has a PEG-ratio under 1 which is considered undervalued

Qiagen N.V. has a price-to-book ratio of 2.69x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Qiagen N.V. has a price-to-sales ratio of 4.31x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue